187 related articles for article (PubMed ID: 15736043)
1. Local immune response in serous papillary carcinoma of the endometrium.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HLA-DR antigen in dysplasia, carcinoma in situ and invasive carcinoma of the gallbladder.
Tamiolakis D; Simopoulos C; Kotini A; Venizelos J; Jivannakis T; Skaphida P; Papadopoulos N
East Afr Med J; 2003 Nov; 80(11):554-8. PubMed ID: 15248671
[TBL] [Abstract][Full Text] [Related]
4. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.
Tamiolakis D; Venizelos J; Papadopoulos N; Lambropoulou M; Papadopoulos E; Simopoulos C
Chirurgia (Bucur); 2005; 100(5):451-6. PubMed ID: 16372671
[TBL] [Abstract][Full Text] [Related]
6. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
[TBL] [Abstract][Full Text] [Related]
7. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
8. GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma.
Idrees MT; Schlosshauer P; Li G; Burstein DE
Histopathology; 2006 Jul; 49(1):75-81. PubMed ID: 16842248
[TBL] [Abstract][Full Text] [Related]
9. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
[TBL] [Abstract][Full Text] [Related]
11. Endometrial intraepithelial carcinoma: a case report and brief review.
Ram M; Bharadwaj M; Yadav R
Indian J Pathol Microbiol; 2008; 51(4):512-4. PubMed ID: 19008579
[TBL] [Abstract][Full Text] [Related]
12. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
Lu B; Chen Q; Zhang X; Cheng L
Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
[TBL] [Abstract][Full Text] [Related]
13. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W
Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.
Holcomb K; Delatorre R; Pedemonte B; McLeod C; Anderson L; Chambers J
Obstet Gynecol; 2002 Dec; 100(6):1290-5. PubMed ID: 12468176
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
[TBL] [Abstract][Full Text] [Related]
16. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between HLA-DR antigen expression and CD4 positive lymphocytic populations in normal mucosa, tubulovillous adenoma, and invasive carcinoma of the colon.
Tamiolakis D; Venizelos I
Cesk Patol; 2006 Apr; 42(2):52-8. PubMed ID: 16715627
[TBL] [Abstract][Full Text] [Related]
18. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression in papillary serous endometrial carcinoma.
Hosford S; Elliott J; Ma ZW; Majeste R; Dubeshter B
Int J Gynecol Cancer; 2003; 13(4):480-4. PubMed ID: 12911725
[TBL] [Abstract][Full Text] [Related]
20. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
McCluggage WG; Sumathi VP; McManus DT
Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]